The Patent Finder

Mindimmune Therapeutics, Inc.

Also on record
Records under this name other than the patents Mindimmune Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 7 of 7 · Back to Mindimmune Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,649,308Benzamide-Containing Compounds and Their Use in the Treatment of Pain
Lapsed on the fee record
Ended May 16, 2025 · High confidence
Lapsed on the fee recordEnded May 16, 2025High confidence
US 9,108,938Cyclic Amines
Lapsed on the fee record
Ended Aug 18, 2023 · High confidence
Lapsed on the fee recordEnded Aug 18, 2023High confidence
US 10,124,010Cyclic Amines
Lapsed on the fee record
Ended Nov 13, 2022 · High confidence
Lapsed on the fee recordEnded Nov 13, 2022High confidence
US 9,861,639Cyclic Amines
Lapsed on the fee record
Ended Jan 9, 2022 · High confidence
Lapsed on the fee recordEnded Jan 9, 2022High confidence
US 9,593,105Cyclic Amines
Lapsed on the fee record
Ended Mar 14, 2021 · High confidence
Lapsed on the fee recordEnded Mar 14, 2021High confidence
US 9,415,055Cyclic Amines
Lapsed on the fee record
Ended Aug 16, 2020 · High confidence
Lapsed on the fee recordEnded Aug 16, 2020High confidence
US 9,133,2045-Membered Heterocyclic Amides And Related Compounds
Lapsed on the fee record
Ended Sep 15, 2019 · Medium confidence
Lapsed on the fee recordEnded Sep 15, 2019Medium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited